SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001178913-24-002017
Filing Date
2024-06-20
Accepted
2024-06-20 16:07:51
Documents
16
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 DEF 14A zk2431584.htm   iXBRL DEF 14A 973319
6 GRAPHIC image00001.jpg GRAPHIC 1744
7 GRAPHIC image00002.jpg GRAPHIC 2315
  Complete submission text file 0001178913-24-002017.txt   1869100

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE entx-20231231.xsd EX-101.SCH 6178
3 XBRL DEFINITION FILE entx-20231231_def.xml EX-101.DEF 5506
4 XBRL LABEL FILE entx-20231231_lab.xml EX-101.LAB 15327
5 XBRL PRESENTATION FILE entx-20231231_pre.xml EX-101.PRE 5545
19 EXTRACTED XBRL INSTANCE DOCUMENT zk2431584_htm.xml XML 243891
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38556 | Film No.: 241056252
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)